Colorectal cancers choosing sides

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1816, Issue 2, 2011, Pages 219-231

  Albuquerque, Cristina ^a   Bakker, Elvira R M ^b   van Veelen, Wendy ^b   Smits, Ron ^b  

^a INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

APC; Colorectal cancer; Mismatch repair; Signalling dosage; Tumour location; Wnt catenin signalling

Indexed keywords

BETA CATENIN;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODY SPECIFICITY; BRAIN TUMOR; COLORECTAL TUMOR; FAMILIAL CANCER; GENETICS; HUMAN; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REVIEW; TUMOR SUPPRESSOR GENE; TURCOT SYNDROME; WNT SIGNALING PATHWAY;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BETA CATENIN; BRAIN NEOPLASMS; COLORECTAL NEOPLASMS; GENES, APC; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASTIC SYNDROMES, HEREDITARY; ORGAN SPECIFICITY; WNT SIGNALING PATHWAY;

MLCS; MLOWN;

EID: 84860590648     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2011.07.005     Document Type: Review

References (128)

1. Wu, X., Chen, V.W., Martin, J., Roffers, S., Groves, F.D., Correa, C.N., Hamilton-Byrd, E., Jemal, A., Subsite-specific colorectal cancer incidence rates and stage distributions among Asians and Pacific islanders in the United States, 1995 to 1999. Cancer Epidemiol. Biomarkers Prev. 13 (2004), 1215–1222.
2. Ionov, Y., Peinado, M.A., Malkhosyan, S., Shibata, D., Perucho, M., Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363 (1993), 558–561.
3. Thibodeau, S.N., Bren, G., Schaid, D., Microsatellite instability in cancer of the proximal colon. Science (New York, N.Y.) 260 (1993), 816–819.
4. Woods, M.O., Younghusband, H.B., Parfrey, P.S., Gallinger, S., McLaughlin, J., Dicks, E., Stuckless, S., Pollett, A., Bapat, B., Mrkonjic, M., de la Chapelle, A., Clendenning, M., Thibodeau, S.N., Simms, M., Dohey, A., Williams, P., Robb, D., Searle, C., Green, J.S., Green, R.C., The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease. Gut, 2010.
5. Boland, C.R., Goel, A., Microsatellite instability in colorectal cancer. Gastroenterology 138 (2010), 2073–2087 e2073.
6. Soreide, K., Janssen, E.A., Soiland, H., Korner, H., Baak, J.P., Microsatellite instability in colorectal cancer. Br. J. Surg. 93 (2006), 395–406.
7. Iacopetta, B., Are there two sides to colorectal cancer?. Int. J. Cancer 101 (2002), 403–408.
8. Fodde, R., Smits, R., Clevers, H., APC, signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer 1 (2001), 55–67.
9. Reya, T., Clevers, H., Wnt signalling in stem cells and cancer. Nature 434 (2005), 843–850.
10. Albuquerque, C., Baltazar, C., Filipe, B., Penha, F., Pereira, T., Smits, R., Cravo, M., Lage, P., Fidalgo, P., Claro, I., Rodrigues, P., Veiga, I., Ramos, J.S., Fonseca, I., Leitao, C.N., Fodde, R., Colorectal cancers show distinct mutation spectra in members of the canonical WNT signaling pathway according to their anatomical location and type of genetic instability. Genes Chromosomes Cancer 49 (2010), 746–759.
11. Polakis, P., Wnt signaling and cancer. Genes Dev. 14 (2000), 1837–1851.
12. Giles, R.H., van Es, J.H., Clevers, H., Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653 (2003), 1–24.
13. Luo, J., Chen, J., Deng, Z.L., Luo, X., Song, W.X., Sharff, K.A., Tang, N., Haydon, R.C., Luu, H.H., He, T.C., Wnt signaling and human diseases: what are the therapeutic implications?. Lab. Invest. 87 (2007), 97–103.
14. Brabletz, T., Jung, A., Hermann, K., Gunther, K., Hohenberger, W., Kirchner, T., Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front. Pathol. Res. Pract. 194 (1998), 701–704.
15. Kirchner, T., Brabletz, T., Patterning and nuclear beta-catenin expression in the colonic adenoma–carcinoma sequence. Analogies with embryonic gastrulation. Am. J. Pathol. 157 (2000), 1113–1121.
16. Hao, X., Tomlinson, I., Ilyas, M., Palazzo, J.P., Talbot, I.C., Reciprocity between membranous and nuclear expression of beta-catenin in colorectal tumours. Virchows Arch. 431 (1997), 167–172.
17. Brabletz, T., Herrmann, K., Jung, A., Faller, G., Kirchner, T., Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am. J. Pathol. 156 (2000), 865–870.
18. Brabletz, T., Jung, A., Spaderna, S., Hlubek, F., Kirchner, T., Opinion: migrating cancer stem cells — an integrated concept of malignant tumour progression. Nat. Rev. Cancer 5 (2005), 744–749.
19. Fodde, R., Brabletz, T., Wnt/beta-catenin signaling in cancer stemness and malignant behavior. Curr. Opin. Cell Biol. 19 (2007), 150–158.
20. Lovig, T., Meling, G.I., Diep, C.B., Thorstensen, L., Norheim Andersen, S., Lothe, R.A., Rognum, T.O., APC and CTNNB1 mutations in a large series of sporadic colorectal carcinomas stratified by the microsatellite instability status. Scand. J. Gastroenterol. 37 (2002), 1184–1193.
21. Polakis, P., The many ways of Wnt in cancer. Curr. Opin. Genet. Dev. 17 (2007), 45–51.
22. Huang, J., Papadopoulos, N., McKinley, A.J., Farrington, S.M., Curtis, L.J., Wyllie, A.H., Zheng, S., Willson, J.K., Markowitz, S.D., Morin, P., Kinzler, K.W., Vogelstein, B., Dunlop, M.G., APC mutations in colorectal tumors with mismatch repair deficiency. Proc. Natl. Acad. Sci. U.S.A. 93 (1996), 9049–9054.
23. Miyaki, M., Iijima, T., Kimura, J., Yasuno, M., Mori, T., Hayashi, Y., Koike, M., Shitara, N., Iwama, T., Kuroki, T., Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res. 59 (1999), 4506–4509.
24. Mirabelli-Primdahl, L., Gryfe, R., Kim, H., Millar, A., Luceri, C., Dale, D., Holowaty, E., Bapat, B., Gallinger, S., Redston, M., Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Res. 59 (1999), 3346–3351.
25. Johnson, V., Volikos, E., Halford, S.E., Eftekhar Sadat, E.T., Popat, S., Talbot, I., Truninger, K., Martin, J., Jass, J., Houlston, R., Atkin, W., Tomlinson, I.P., Silver, A.R., Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome. Gut 54 (2005), 264–267.
26. Shitoh, K., Furukawa, T., Kojima, M., Konishi, F., Miyaki, M., Tsukamoto, T., Nagai, H., Frequent activation of the beta-catenin–Tcf signaling pathway in nonfamilial colorectal carcinomas with microsatellite instability. Genes Chromosomes Cancer 30 (2001), 32–37.
27. Shimizu, Y., Ikeda, S., Fujimori, M., Kodama, S., Nakahara, M., Okajima, M., Asahara, T., Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability. Genes Chromosomes Cancer 33 (2002), 73–81.
28. Suraweera, N., Robinson, J., Volikos, E., Guenther, T., Talbot, I., Tomlinson, I., Silver, A., Mutations within Wnt pathway genes in sporadic colorectal cancers and cell lines. Int. J. Cancer 119 (2006), 1837–1842.
29. Liu, W., Dong, X., Mai, M., Seelan, R.S., Taniguchi, K., Krishnadath, K.K., Halling, K.C., Cunningham, J.M., Qian, C., Christensen, E., Roche, P.C., Smith, D.I., Thibodeau, S.N., Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat. Genet. 26 (2000), 146–147.
30. Koinuma, K., Yamashita, Y., Liu, W., Hatanaka, H., Kurashina, K., Wada, T., Takada, S., Kaneda, R., Choi, Y.L., Fujiwara, S.I., Miyakura, Y., Nagai, H., Mano, H., Epigenetic silencing of AXIN2 in colorectal carcinoma with microsatellite instability. Oncogene 25 (2006), 139–146.
31. Kohler, E.M., Chandra, S.H., Behrens, J., Schneikert, J., Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours. Hum. Mol. Genet. 18 (2009), 213–226.
32. Munemitsu, S., Albert, I., Souza, B., Rubinfeld, B., Polakis, P., Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl. Acad. Sci. U.S.A. 92 (1995), 3046–3050.
33. Rubinfeld, B., Albert, I., Porfiri, E., Munemitsu, S., Polakis, P., Loss of beta-catenin regulation by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene. Cancer Res. 57 (1997), 4624–4630.
34. Dihlmann, S., Gebert, J., Siermann, A., Herfarth, C., von Knebel Doeberitz, M., Dominant negative effect of the APC1309 mutation: a possible explanation for genotype–phenotype correlations in familial adenomatous polyposis. Cancer Res. 59 (1999), 1857–1860.
35. Su, L.K., Barnes, C.J., Yao, W., Qi, Y., Lynch, P.M., Steinbach, G., Inactivation of germline mutant APC alleles by attenuated somatic mutations: a molecular genetic mechanism for attenuated familial adenomatous polyposis. Am. J. Hum. Genet. 67 (2000), 582–590.
36. Smits, R., Kielman, M.F., Breukel, C., Zurcher, C., Neufeld, K., Jagmohan-Changur, S., Hofland, N., van Dijk, J., White, R., Edelmann, W., Kucherlapati, R., Khan, P.M., Fodde, R., Apc1638T: a mouse model delineating critical domains of the adenomatous polyposis coli protein involved in tumorigenesis and development. Genes Dev. 13 (1999), 1309–1321.
37. Kielman, M.F., Rindapaa, M., Gaspar, C., van Poppel, N., Breukel, C., van Leeuwen, S., Taketo, M.M., Roberts, S., Smits, R., Fodde, R., Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling. Nat. Genet. 32 (2002), 594–605.
38. Gaspar, C., Franken, P., Molenaar, L., Breukel, C., van der Valk, M., Smits, R., Fodde, R., A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis. PLoS Genet., 5, 2009, e1000547.
39. Henderson, B.R., Nuclear–cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat. Cell Biol. 2 (2000), 653–660.
40. Galea, M.A., Eleftheriou, A., Henderson, B.R., ARM domain-dependent nuclear import of adenomatous polyposis coli protein is stimulated by the B56 alpha subunit of protein phosphatase 2A. J. Biol. Chem. 276 (2001), 45833–45839.
41. Schneikert, J., Grohmann, A., Behrens, J., Truncated APC regulates the transcriptional activity of beta-catenin in a cell cycle dependent manner. Hum. Mol. Genet. 16 (2007), 199–209.
42. Kohler, E.M., Derungs, A., Daum, G., Behrens, J., Schneikert, J., Functional definition of the mutation cluster region of adenomatous polyposis coli in colorectal tumours. Hum. Mol. Genet. 17 (2008), 1978–1987.
43. Wang, Z., Vogelstein, B., Kinzler, K.W., Phosphorylation of beta-catenin at S33, S37, or T41 can occur in the absence of phosphorylation at T45 in colon cancer cells. Cancer Res. 63 (2003), 5234–5235.
44. Rosin-Arbesfeld, R., Cliffe, A., Brabletz, T., Bienz, M., Nuclear export of the APC tumour suppressor controls beta-catenin function in transcription. EMBO J. 22 (2003), 1101–1113.
45. Lamlum, H., Ilyas, M., Rowan, A., Clark, S., Johnson, V., Bell, J., Frayling, I., Efstathiou, J., Pack, K., Payne, S., Roylance, R., Gorman, P., Sheer, D., Neale, K., Phillips, R., Talbot, I., Bodmer, W., Tomlinson, I., The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's ‘two-hit’ hypothesis. Nat. Med. 5 (1999), 1071–1075.
46. Smits, R., Hofland, N., Edelmann, W., Geugien, M., Jagmohan-Changur, S., Albuquerque, C., Breukel, C., Kucherlapati, R., Kielman, M.F., Fodde, R., Somatic Apc mutations are selected upon their capacity to inactivate the beta-catenin downregulating activity. Genes Chromosomes Cancer 29 (2000), 229–239.
47. Rowan, A.J., Lamlum, H., Ilyas, M., Wheeler, J., Straub, J., Papadopoulou, A., Bicknell, D., Bodmer, W.F., Tomlinson, I.P., APC mutations in sporadic colorectal tumors: a mutational “hotspot” and interdependence of the “two hits”. Proc. Natl. Acad. Sci. U.S.A. 97 (2000), 3352–3357.
48. Albuquerque, C., Breukel, C., van der Luijt, R., Fidalgo, P., Lage, P., Slors, F.J., Leitao, C.N., Fodde, R., Smits, R., The ‘just-right’ signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. Hum. Mol. Genet. 11 (2002), 1549–1560.
49. Crabtree, M., Sieber, O.M., Lipton, L., Hodgson, S.V., Lamlum, H., Thomas, H.J., Neale, K., Phillips, R.K., Heinimann, K., Tomlinson, I.P., Refining the relation between ‘first hits’ and ‘second hits’ at the APC locus: the ‘loose fit’ model and evidence for differences in somatic mutation spectra among patients. Oncogene 22 (2003), 4257–4265.
50. Buchert, M., Athineos, D., Abud, H.E., Burke, Z.D., Faux, M.C., Samuel, M.S., Jarnicki, A.G., Winbanks, C.E., Newton, I.P., Meniel, V.S., Suzuki, H., Stacker, S.A., Nathke, I.S., Tosh, D., Huelsken, J., Clarke, A.R., Heath, J.K., Sansom, O.J., Ernst, M., Genetic dissection of differential signaling threshold requirements for the Wnt/beta-catenin pathway in vivo. PLoS Genet., 6, 2010, e1000816.
51. Li, Q., Ishikawa, T.O., Oshima, M., Taketo, M.M., The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis. Cancer Res. 65 (2005), 8622–8627.
52. Kim, K., Pang, K.M., Evans, M., Hay, E.D., Overexpression of beta-catenin induces apoptosis independent of its transactivation function with LEF-1 or the involvement of major G1 cell cycle regulators. Mol. Biol. Cell 11 (2000), 3509–3523.
53. Damalas, A., Ben-Ze'ev, A., Simcha, I., Shtutman, M., Leal, J.F., Zhurinsky, J., Geiger, B., Oren, M., Excess beta-catenin promotes accumulation of transcriptionally active p53. EMBO J. 18 (1999), 3054–3063.
54. Romagnolo, B., Berrebi, D., Saadi-Keddoucci, S., Porteu, A., Pichard, A.L., Peuchmaur, M., Vandewalle, A., Kahn, A., Perret, C., Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin. Cancer Res. 59 (1999), 3875–3879.
55. He, T.C., Sparks, A.B., Rago, C., Hermeking, H., Zawel, L., da Costa, L.T., Morin, P.J., Vogelstein, B., Kinzler, K.W., Identification of c-MYC as a target of the APC pathway. Science (New York, N.Y.) 281 (1998), 1509–1512.
56. Sansom, O.J., Meniel, V.S., Muncan, V., Phesse, T.J., Wilkins, J.A., Reed, K.R., Vass, J.K., Athineos, D., Clevers, H., Clarke, A.R., Myc deletion rescues Apc deficiency in the small intestine. Nature 446 (2007), 676–679.
57. Murphy, D.J., Junttila, M.R., Pouyet, L., Karnezis, A., Shchors, K., Bui, D.A., Brown-Swigart, L., Johnson, L., Evan, G.I., Distinct thresholds govern Myc's biological output in vivo. Cancer Cell 14 (2008), 447–457.
58. Tejpar, S., Nollet, F., Li, C., Wunder, J.S., Michils, G., dal Cin, P., Van Cutsem, E., Bapat, B., van Roy, F., Cassiman, J.J., Alman, B.A., Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 18 (1999), 6615–6620.
59. Salas, S., Chibon, F., Noguchi, T., Terrier, P., Ranchere-Vince, D., Lagarde, P., Benard, J., Forget, S., Blanchard, C., Domont, J., Bonvalot, S., Guillou, L., Leroux, A., Mechine-Neuville, A., Schoffski, P., Lae, M., Collin, F., Verola, O., Carbonnelle, A., Vescovo, L., Bui, B., Brouste, V., Sobol, H., Aurias, A., Coindre, J.M., Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors. Genes Chromosomes Cancer 49 (2010), 560–568.
60. Latchford, A., Volikos, E., Johnson, V., Rogers, P., Suraweera, N., Tomlinson, I., Phillips, R., Silver, A., APC mutations in FAP-associated desmoid tumours are non-random but not ‘just right’. Hum. Mol. Genet. 16 (2007), 78–82.
61. Toyooka, M., Konishi, M., Kikuchi-Yanoshita, R., Iwama, T., Miyaki, M., Somatic mutations of the adenomatous polyposis coli gene in gastroduodenal tumors from patients with familial adenomatous polyposis. Cancer Res. 55 (1995), 3165–3170.
62. Breuhahn, K., Singh, S., Schirmacher, P., Blaker, H., Large-scale N-terminal deletions but not point mutations stabilize beta-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis. J. Pathol. 215 (2008), 300–307.
63. Abraham, S.C., Nobukawa, B., Giardiello, F.M., Hamilton, S.R., Wu, T.T., Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am. J. Pathol. 157 (2000), 747–754.
64. Groves, C., Lamlum, H., Crabtree, M., Williamson, J., Taylor, C., Bass, S., Cuthbert-Heavens, D., Hodgson, S., Phillips, R., Tomlinson, I., Mutation cluster region, association between germline and somatic mutations and genotype–phenotype correlation in upper gastrointestinal familial adenomatous polyposis. Am. J. Pathol. 160 (2002), 2055–2061.
65. Nieuwenhuis, M.H., Vasen, H.F., Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. Crit. Rev. Oncol. Hematol. 61 (2007), 153–161.
66. Sturt, N.J., Gallagher, M.C., Bassett, P., Philp, C.R., Neale, K.F., Tomlinson, I.P., Silver, A.R., Phillips, R.K., Evidence for genetic predisposition to desmoid tumours in familial adenomatous polyposis independent of the germline APC mutation. Gut 53 (2004), 1832–1836.
67. Fodde, R., Smits, R., Disease model: familial adenomatous polyposis. Trends Mol. Med. 7 (2001), 369–373.
68. Gaspar, C., Fodde, R., APC dosage effects in tumorigenesis and stem cell differentiation. Int. J. Dev. Biol. 48 (2004), 377–386.
69. Taketo, M.M., Edelmann, W., Mouse models of colon cancer. Gastroenterology 136 (2009), 780–798.
70. Smits, R., van der Houven, W., van Oordt, A., Luz, C., Zurcher, S., Jagmohan-Changur, C., Breukel, P.M., Khan, R. Fodde, Apc1638N: a mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts. Gastroenterology 114 (1998), 275–283.
71. Nusse, R., van Ooyen, A., Cox, D., Fung, Y.K., Varmus, H., Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature 307 (1984), 131–136.
72. Tsukamoto, A.S., Grosschedl, R., Guzman, R.C., Parslow, T., Varmus, H.E., Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55 (1988), 619–625.
73. Imbert, A., Eelkema, R., Jordan, S., Feiner, H., Cowin, P., Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland. J. Cell Biol. 153 (2001), 555–568.
74. Michaelson, J.S., Leder, P., beta-Catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland. Oncogene 20 (2001), 5093–5099.
75. Tischfield, J.A., Loss of heterozygosity or: how I learned to stop worrying and love mitotic recombination. Am. J. Hum. Genet. 61 (1997), 995–999.
76. Tichy, E.D., Stambrook, P.J., DNA repair in murine embryonic stem cells and differentiated cells. Exp. Cell Res. 314 (2008), 1929–1936.
77. Haigis, K.M., Dove, W.F., A Robertsonian translocation suppresses a somatic recombination pathway to loss of heterozygosity. Nat. Genet. 33 (2003), 33–39.
78. Kuraguchi, M., Ohene-Baah, N.Y., Sonkin, D., Bronson, R.T., Kucherlapati, R., Genetic mechanisms in apc-mediated mammary tumorigenesis. PLoS Genet., 5, 2009, e1000367.
79. Sparks, A.B., Morin, P.J., Vogelstein, B., Kinzler, K.W., Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res. 58 (1998), 1130–1134.
80. Kim, I.J., Kang, H.C., Park, J.H., Shin, Y., Ku, J.L., Lim, S.B., Park, S.Y., Jung, S.Y., Kim, H.K., Park, J.G., Development and applications of a beta-catenin oligonucleotide microarray: beta-catenin mutations are dominantly found in the proximal colon cancers with microsatellite instability. Clin. Cancer Res. 9 (2003), 2920–2925.
81. Luchtenborg, M., Weijenberg, M.P., Wark, P.A., Saritas, A.M., Roemen, G.M., van Muijen, G.N., de Bruine, A.P., van den Brandt, P.A., de Goeij, A.F., Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study. BMC Cancer, 5, 2005, 160.
82. Chan, E.F., Gat, U., McNiff, J.M., Fuchs, E., A common human skin tumour is caused by activating mutations in beta-catenin. Nat. Genet. 21 (1999), 410–413.
83. Austinat, M., Dunsch, R., Wittekind, C., Tannapfel, A., Gebhardt, R., Gaunitz, F., Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma. Mol. Cancer, 7, 2008, 21.
84. Nathke, I., Cytoskeleton out of the cupboard: colon cancer and cytoskeletal changes induced by loss of APC. Nat. Rev. Cancer 6 (2006), 967–974.
85. Fodde, R., Kuipers, J., Rosenberg, C., Smits, R., Kielman, M., Gaspar, C., van Es, J.H., Breukel, C., Wiegant, J., Giles, R.H., Clevers, H., Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat. Cell Biol. 3 (2001), 433–438.
86. Kaplan, K.B., Burds, A.A., Swedlow, J.R., Bekir, S.S., Sorger, P.K., Nathke, I.S., A role for the Adenomatous Polyposis Coli protein in chromosome segregation. Nat. Cell Biol. 3 (2001), 429–432.
87. Phelps, R.A., Chidester, S., Dehghanizadeh, S., Phelps, J., Sandoval, I.T., Rai, K., Broadbent, T., Sarkar, S., Burt, R.W., Jones, D.A., A two-step model for colon adenoma initiation and progression caused by APC loss. Cell 137 (2009), 623–634.
88. Hamada, F., Bienz, M., The APC tumor suppressor binds to C-terminal binding protein to divert nuclear beta-catenin from TCF. Dev. Cell 7 (2004), 677–685.
89. Fodde, R., Tomlinson, I., Nuclear beta-catenin expression and Wnt signalling: in defence of the dogma. J. Pathol. 221 (2010), 239–241.
90. Munne, A., Fabre, M., Marinoso, M.L., Gallen, M., Real, F.X., Nuclear beta-catenin in colorectal tumors: to freeze or not to freeze?. J. Histochem. Cytochem. 47 (1999), 1089–1094.
91. Obrador-Hevia, A., Chin, S.F., Gonzalez, S., Rees, J., Vilardell, F., Greenson, J.K., Cordero, D., Moreno, V., Caldas, C., Capella, G., Oncogenic KRAS is not necessary for Wnt signalling activation in APC-associated FAP adenomas. J. Pathol. 221 (2010), 57–67.
92. Harada, N., Tamai, Y., Ishikawa, T., Sauer, B., Takaku, K., Oshima, M., Taketo, M.M., Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J. 18 (1999), 5931–5942.
93. Aoki, T., Takeda, S., Yanagisawa, A., Kato, Y., Ajioka, Y., Watanabe, H., Kudo, S., Nakamura, Y., APC and p53 mutations in de novo colorectal adenocarcinomas. Hum. Mutat. 3 (1994), 342–346.
94. Smith, G., Carey, F.A., Beattie, J., Wilkie, M.J., Lightfoot, T.J., Coxhead, J., Garner, R.C., Steele, R.J., Wolf, C.R., Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer. Proc. Natl. Acad. Sci. U.S.A. 99 (2002), 9433–9438.
95. Miyaki, M., Iijima, T., Ohue, M., Kita, Y., Hishima, T., Kuroki, T., Iwama, T., Mori, T., A novel case with germline p53 gene mutation having concurrent multiple primary colon tumours. Gut 52 (2003), 304–306.
96. Aust, D.E., Terdiman, J.P., Willenbucher, R.F., Chang, C.G., Molinaro-Clark, A., Baretton, G.B., Loehrs, U., Waldman, F.M., The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: a mutational analysis. Cancer 94 (2002), 1421–1427.
97. Scholtka, B., Schneider, M., Melcher, R., Katzenberger, T., Friedrich, D., Berghof-Jager, K., Scheppach, W., Steinberg, P., A gene marker panel covering the Wnt and the Ras–Raf–MEK–MAPK signalling pathways allows to detect gene mutations in 80% of early (UICC I) colon cancer stages in humans. Cancer Epidemiol. 33 (2009), 123–129.
98. Ku, J.L., Shin, Y.K., Kim, D.W., Kim, K.H., Choi, J.S., Hong, S.H., Jeon, Y.K., Kim, S.H., Kim, H.S., Park, J.H., Kim, I.J., Park, J.G., Establishment and characterization of 13 human colorectal carcinoma cell lines: mutations of genes and expressions of drug-sensitivity genes and cancer stem cell markers. Carcinogenesis 31 (2010), 1003–1009.
99. Rodenas-Cuadrado, P., Howarth, K., Lewis, A., Mallappa, S., Jeffery, R., Rodriguez-Justo, M., Clark, S.K., East, J.E., Travis, S., Tomlinson, I., Leedham, S., Human and mouse gastrointestinal tumor distribution is selected according to a basal Wnt signalling gradient. Gastroenterology, 140, 2011, S-128 abstract 763.
100. Minoo, P., Zlobec, I., Peterson, M., Terracciano, L., Lugli, A., Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles. Int. J. Oncol. 37 (2010), 707–718.
101. Shoemaker, A.R., Moser, A.R., Dove, W.F., N-ethyl-N-nitrosourea treatment of multiple intestinal neoplasia (Min) mice: age-related effects on the formation of intestinal adenomas, cystic crypts, and epidermoid cysts. Cancer Res. 55 (1995), 4479–4485.
102. Fodde, R., Edelmann, W., Yang, K., van Leeuwen, C., Carlson, C., Renault, B., Breukel, C., Alt, E., Lipkin, M., Khan, P.M., Kucherlapati, R., A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc. Natl. Acad. Sci. U.S.A. 91 (1994), 8969–8973.
103. van der Houven, C.W., van Oordt, R., Smits, S.L., Williamson, A., Luz, P.M., Khan, R., van der Fodde, A.J., Eb, M.L. Breuer, Intestinal and extra-intestinal tumor multiplicities in the Apc1638N mouse model after exposure to X-rays. Carcinogenesis 18 (1997), 2197–2203.
104. Haigis, K.M., Hoff, P.D., White, A., Shoemaker, A.R., Halberg, R.B., Dove, W.F., Tumor regionality in the mouse intestine reflects the mechanism of loss of Apc function. Proc. Natl. Acad. Sci. U.S.A. 101 (2004), 9769–9773.
105. Pollard, P., Deheragoda, M., Segditsas, S., Lewis, A., Rowan, A., Howarth, K., Willis, L., Nye, E., McCart, A., Mandir, N., Silver, A., Goodlad, R., Stamp, G., Cockman, M., East, P., Spencer-Dene, B., Poulsom, R., Wright, N., Tomlinson, I., The Apc 1322T mouse develops severe polyposis associated with submaximal nuclear beta-catenin expression. Gastroenterology 136 (2009), 2204–2213 e2201–e2213.
106. Aoki, K., Tamai, Y., Horiike, S., Oshima, M., Taketo, M.M., Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Delta716 Cdx2+/− compound mutant mice. Nat. Genet. 35 (2003), 323–330.
107. Shoemaker, A.R., Luongo, C., Moser, A.R., Marton, L.J., Dove, W.F., Somatic mutational mechanisms involved in intestinal tumor formation in Min mice. Cancer Res. 57 (1997), 1999–2006.
108. Hinoi, T., Akyol, A., Theisen, B.K., Ferguson, D.O., Greenson, J.K., Williams, B.O., Cho, K.R., Fearon, E.R., Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation. Cancer Res. 67 (2007), 9721–9730.
109. Robanus-Maandag, E.C., Koelink, P.J., Breukel, C., Salvatori, D.C., Jagmohan-Changur, S.C., Bosch, C.A., Verspaget, H.W., Devilee, P., Fodde, R., Smits, R., A new conditional Apc-mutant mouse model for colorectal cancer. Carcinogenesis 31 (2010), 946–952.
110. Macfarlane, G.T., Gibson, G.R., Cummings, J.H., Comparison of fermentation reactions in different regions of the human colon. J. Appl. Bacteriol. 72 (1992), 57–64.
111. Bordonaro, M., Lazarova, D.L., Sartorelli, A.C., Hyperinduction of Wnt activity: a new paradigm for the treatment of colorectal cancer?. Oncol. Res. 17 (2008), 1–9.
112. Thomas, L.A., Veysey, M.J., French, G., Hylemon, P.B., Murphy, G.M., Dowling, R.H., Bile acid metabolism by fresh human colonic contents: a comparison of caecal versus faecal samples. Gut 49 (2001), 835–842.
113. Bernstein, H., Bernstein, C., Payne, C.M., Dvorakova, K., Garewal, H., Bile acids as carcinogens in human gastrointestinal cancers. Mutat. Res. 589 (2005), 47–65.
114. Glebov, O.K., Rodriguez, L.M., Nakahara, K., Jenkins, J., Cliatt, J., Humbyrd, C.J., DeNobile, J., Soballe, P., Simon, R., Wright, G., Lynch, P., Patterson, S., Lynch, H., Gallinger, S., Buchbinder, A., Gordon, G., Hawk, E., Kirsch, I.R., Distinguishing right from left colon by the pattern of gene expression. Cancer Epidemiol. Biomarkers Prev. 12 (2003), 755–762.
115. Mizoshita, T., Inada, K., Tsukamoto, T., Kodera, Y., Yamamura, Y., Hirai, T., Kato, T., Joh, T., Itoh, M., Tatematsu, M., Expression of Cdx1 and Cdx2 mRNAs and relevance of this expression to differentiation in human gastrointestinal mucosa—with special emphasis on participation in intestinal metaplasia of the human stomach. Gastric Cancer 4 (2001), 185–191.
116. Olschwang, S., Hamelin, R., Laurent-Puig, P., Thuille, B., De Rycke, Y., Li, Y.J., Muzeau, F., Girodet, J., Salmon, R.J., Thomas, G., Alternative genetic pathways in colorectal carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 94 (1997), 12122–12127.
117. Beroud, C., Soussi, T., APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res. 24 (1996), 121–124.
118. Andrew, S.E., Reitmair, A.H., Fox, J., Hsiao, L., Francis, A., McKinnon, M., Mak, T.W., Jirik, F.R., Base transitions dominate the mutational spectrum of a transgenic reporter gene in MSH2 deficient mice. Oncogene 15 (1997), 123–129.
119. Shin, C.Y., Mellon, I., Turker, M.S., Multiple mutations are common at mouse Aprt in genotoxin-exposed mismatch repair deficient cells. Oncogene 21 (2002), 1768–1776.
120. Baross-Francis, A., Makhani, N., Liskay, R.M., Jirik, F.R., Elevated mutant frequencies and increased C:G → T:A transitions in Mlh1−/− versus Pms2−/− murine small intestinal epithelial cells. Oncogene 20 (2001), 619–625.
121. Duval, A., Hamelin, R., Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. Cancer Res. 62 (2002), 2447–2454.
122. Konishi, M., Kikuchi-Yanoshita, R., Tanaka, K., Muraoka, M., Onda, A., Okumura, Y., Kishi, N., Iwama, T., Mori, T., Koike, M., Ushio, K., Chiba, M., Nomizu, S., Konishi, F., Utsunomiya, J., Miyaki, M., Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 111 (1996), 307–317.
123. Domingo, E., Espin, E., Armengol, M., Oliveira, C., Pinto, M., Duval, A., Brennetot, C., Seruca, R., Hamelin, R., Yamamoto, H., Schwartz, S. Jr., Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation. Genes Chromosomes Cancer 39 (2004), 138–142.
124. Chia, I.V., Costantini, F., Mouse axin and axin2/conductin proteins are functionally equivalent in vivo. Mol. Cell. Biol. 25 (2005), 4371–4376.
125. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., Fan, R.S., Zborowska, E., Kinzler, K.W., Vogelstein, B., et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science (New York, N.Y.) 268 (1995), 1336–1338.
126. Rajagopalan, H., Bardelli, A., Lengauer, C., Kinzler, K.W., Vogelstein, B., Velculescu, V.E., RAF/RAS oncogenes and mismatch–repair status. Nature, 418, 2002, 934.
127. McGivern, A., Wynter, C.V., Whitehall, V.L., Kambara, T., Spring, K.J., Walsh, M.D., Barker, M.A., Arnold, S., Simms, L.A., Leggett, B.A., Young, J., Jass, J.R., Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer. Fam. Cancer 3 (2004), 101–107.
128. Krishna, M., Narang, H., The complexity of mitogen-activated protein kinases (MAPKs) made simple. Cell. Mol. Life Sci. 65 (2008), 3525–3544.